Virta Health, with its telemedicine nutrition therapy program combined with GLP-1 treatment, has clinically demonstrated its ability to keep patients from weight gain following GLP-1 deprescription
Post-surgical (rehabilitation) phase: After surgery, PDA may help reduce pain sensations, accelerate tissue repair, and support earlier functional milestones (e.g., earlier weight-bearing and range-of-motion goals)
An inguinal nodal clearance was performed
noted a 75% failure rate after cystectomy and Kock pouch: 6 of 8 patients had persistent pain, including 4 with pain in the pouch
Food and Drug Administration (2023) Oral semaglutide versus empagliflozin in patients with Type 2 diabetes uncontrolled on metformin: The PIONEER 2 trial, Diabetes Care (2019) Empagliflozin, cardiovascular outcomes, and mortality in Type 2 diabetes, The New England Journal of Medicine (2015) Empagliflozin in heart failure with a preserved ejection fraction, The New England Journal of Medicine e (2021) Empagliflozin in patients with chronic kidney disease, The New England Journal of Medicine (2022) Semaglutide and cardiovascular outcomes in obesity without diabetes, The New England Journal of Medicine (2023) Effects of semaglutide on chronic kidney disease in patients with Type 2 diabetes, The New England Journal of Medicine (2024) Ozempic drug label information, DailyMed (2023) Jardiance drug label information, DailyMed (2023) Effect of semaglutide on the pharmacokinetics of metformin, warfarin, atorvastatin, and digoxin in healthy subjects, Clinical Pharmacokinetics (2017) Semaglutide injection, Medline Plus (2024) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
For patients, the most helpful next step is a careful conversation with a qualified healthcare professional who can explain the substance being discussed, the current regulatory context, and what questions should come first
